Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: COSCIENS BIOPHARMA INC(CSCID) the Revenue is 1.888 M (+36.12%);the EBIT is -730 K (+72.55%);the EPS is 10.27 (+394.5%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B36.12%
----
----
EBIT
-0.00B72.55%
----
----
EPS
10.269394.51%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf